FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604308107> ?p ?o ?g. }

• W2604308107 endingPage "293" @default.
• W2604308107 startingPage "279" @default.
• W2604308107 abstract "Multiple Sclerosis (MS) is a chronic pathology affecting the Central Nervous System characterized by inflammatory processes that lead to demyelination and neurodegeneration. In MS treatment, disease modifying therapies (DMTs) are essential to reduce disease progression by suppressing the inflammatory response responsible for promoting lesion formation. Recently, in addition to the classical injectable DMTs like Interferons and Glatiramer acetate, new orally administered drugs have been approved for MS therapy: dimethyl fumarate, teriflunomide and fingolimod. These drugs act with different mechanisms on the immune system, in order to suppress the harmful inflammatory process. An additional layer of complexity is introduced by the influence of polymorphic gene variants in the Human Leukocyte Antigen region on the risk of developing MS and its progression. To date, pharmacogenomic studies have mainly focused on the patient's response following admission of injectable drugs. Therefore, greater consideration must be made to pharmacogenomics with a view to developing more effective and personalized therapies. This review aims to shed light on the mechanism of action of the new oral drugs dimethyl fumarate, teriflunomide and fingolimod, taking into account both the importance of immunogenetics in drug response and pharmacogenomic studies." @default.
• W2604308107 created "2017-04-14" @default.
• W2604308107 creator A5008399548 @default.
• W2604308107 creator A5036405171 @default.
• W2604308107 creator A5038827932 @default.
• W2604308107 creator A5046834604 @default.
• W2604308107 creator A5070949179 @default.
• W2604308107 creator A5074352991 @default.
• W2604308107 creator A5089479709 @default.
• W2604308107 date "2017-06-01" @default.
• W2604308107 modified "2023-10-16" @default.
• W2604308107 title "What’s new about oral treatments in Multiple Sclerosis? Immunogenetics still under question" @default.
• W2604308107 cites W119489668 @default.
• W2604308107 cites W1494441064 @default.
• W2604308107 cites W1543329660 @default.
• W2604308107 cites W1547181907 @default.
• W2604308107 cites W1573130413 @default.
• W2604308107 cites W1815523758 @default.
• W2604308107 cites W1828576284 @default.
• W2604308107 cites W1930623285 @default.
• W2604308107 cites W1963793744 @default.
• W2604308107 cites W1965736363 @default.
• W2604308107 cites W1967704295 @default.
• W2604308107 cites W1967838438 @default.
• W2604308107 cites W1968364857 @default.
• W2604308107 cites W1970667136 @default.
• W2604308107 cites W1972242699 @default.
• W2604308107 cites W1973808919 @default.
• W2604308107 cites W1974301987 @default.
• W2604308107 cites W1974941970 @default.
• W2604308107 cites W1976805592 @default.
• W2604308107 cites W1978094617 @default.
• W2604308107 cites W1979811627 @default.
• W2604308107 cites W1980748156 @default.
• W2604308107 cites W1983382084 @default.
• W2604308107 cites W1983783995 @default.
• W2604308107 cites W1991554738 @default.
• W2604308107 cites W1994366017 @default.
• W2604308107 cites W1997327044 @default.
• W2604308107 cites W1998017118 @default.
• W2604308107 cites W2001504083 @default.
• W2604308107 cites W2002436119 @default.
• W2604308107 cites W2003184738 @default.
• W2604308107 cites W2005467120 @default.
• W2604308107 cites W2005506388 @default.
• W2604308107 cites W2007541166 @default.
• W2604308107 cites W2008817720 @default.
• W2604308107 cites W2010453211 @default.
• W2604308107 cites W2011015155 @default.
• W2604308107 cites W2012165445 @default.
• W2604308107 cites W2013199340 @default.
• W2604308107 cites W2013555370 @default.
• W2604308107 cites W2013810114 @default.
• W2604308107 cites W2014127183 @default.
• W2604308107 cites W2014746073 @default.
• W2604308107 cites W2015238396 @default.
• W2604308107 cites W2017665309 @default.
• W2604308107 cites W2019582599 @default.
• W2604308107 cites W2020682263 @default.
• W2604308107 cites W2021538155 @default.
• W2604308107 cites W2022905263 @default.
• W2604308107 cites W2024253875 @default.
• W2604308107 cites W2024444969 @default.
• W2604308107 cites W2024921751 @default.
• W2604308107 cites W2025161685 @default.
• W2604308107 cites W2026787131 @default.
• W2604308107 cites W2027129171 @default.
• W2604308107 cites W2029745420 @default.
• W2604308107 cites W2035248522 @default.
• W2604308107 cites W2037903212 @default.
• W2604308107 cites W2040547343 @default.
• W2604308107 cites W2042067959 @default.
• W2604308107 cites W2043591841 @default.
• W2604308107 cites W2044022462 @default.
• W2604308107 cites W2044645437 @default.
• W2604308107 cites W2045322838 @default.
• W2604308107 cites W2046128399 @default.
• W2604308107 cites W2049363669 @default.
• W2604308107 cites W2050070110 @default.
• W2604308107 cites W2050473420 @default.
• W2604308107 cites W2052701858 @default.
• W2604308107 cites W2053167918 @default.
• W2604308107 cites W2054129577 @default.
• W2604308107 cites W2054321478 @default.
• W2604308107 cites W2054655809 @default.
• W2604308107 cites W2054673787 @default.
• W2604308107 cites W2055606644 @default.
• W2604308107 cites W2056473837 @default.
• W2604308107 cites W2062517636 @default.
• W2604308107 cites W2063858768 @default.
• W2604308107 cites W2066791546 @default.
• W2604308107 cites W2066922594 @default.
• W2604308107 cites W2068690343 @default.
• W2604308107 cites W2069907950 @default.
• W2604308107 cites W2072718666 @default.
• W2604308107 cites W2074354044 @default.
• W2604308107 cites W2074492379 @default.
• W2604308107 cites W2075006858 @default.

• next